Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
| dc.contributor.author | Christiansen, Sara Nysom | |
| dc.contributor.author | Horskjær Rasmussen, Simon | |
| dc.contributor.author | Pons, Marion | |
| dc.contributor.author | Michelsen, Brigitte | |
| dc.contributor.author | Glintborg, Bente | |
| dc.contributor.author | Gudbjornsson, Bjorn | |
| dc.contributor.author | Grondal, Gerdur | |
| dc.contributor.author | Vencovsky, Jiri | |
| dc.contributor.author | Loft, Anne Gitte | |
| dc.contributor.author | Rotar, Ziga | |
| dc.contributor.author | Pirkmajer, Katja Perdan | |
| dc.contributor.author | Nissen, Michael J. | |
| dc.contributor.author | Baranová, Jana | |
| dc.contributor.author | Macfarlane, Gary J. | |
| dc.contributor.author | Jones, Gareth T. | |
| dc.contributor.author | Iannone, Florenzo | |
| dc.contributor.author | Caporali, Roberto | |
| dc.contributor.author | Laas, Karin | |
| dc.contributor.author | Vorobjov, Sigrid | |
| dc.contributor.author | Giuseppe, Daniela Di | |
| dc.contributor.author | Olofsson, Tor | |
| dc.contributor.author | Provan, Sella Aarrestad | |
| dc.contributor.author | Fagerli, Karen Minde | |
| dc.contributor.author | Castrejon, Isabel | |
| dc.contributor.author | Otero-Varela, Lucia | |
| dc.contributor.author | van de Sande, Marleen | |
| dc.contributor.author | van der Horst-Bruinsma, Irene | |
| dc.contributor.author | Nordström, Dan | |
| dc.contributor.author | Kuusalo, Laura | |
| dc.contributor.author | Bernardes, Miguel | |
| dc.contributor.author | Hetland, Merete Lund | |
| dc.contributor.author | Østergaard, Mikkel | |
| dc.contributor.author | Midtbøll Ørnbjerg, Lykke | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-05-02T14:32:00Z | |
| dc.date.available | 2024-05-02T14:32:00Z | |
| dc.date.issued | 2024-04 | |
| dc.description | On behalf of the EuroSpA Scientific Committee, the authors acknowledge Novartis Pharma AG for supporting the EuroSpA collaboration. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 2416396 | |
| dc.identifier | 288799985 | |
| dc.identifier | 320e40c0-abec-41ac-97e1-04632d398d8d | |
| dc.identifier | 85184021202 | |
| dc.identifier | 38301349 | |
| dc.identifier.citation | Christiansen, S N, Horskjær Rasmussen, S, Pons, M, Michelsen, B, Glintborg, B, Gudbjornsson, B, Grondal, G, Vencovsky, J, Loft, A G, Rotar, Z, Pirkmajer, K P, Nissen, M J, Baranová, J, Macfarlane, G J, Jones, G T, Iannone, F, Caporali, R, Laas, K, Vorobjov, S, Giuseppe, D D, Olofsson, T, Provan, S A, Fagerli, K M, Castrejon, I, Otero-Varela, L, van de Sande, M, van der Horst-Bruinsma, I, Nordström, D, Kuusalo, L, Bernardes, M, Hetland, M L, Østergaard, M & Midtbøll Ørnbjerg, L 2024, 'Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice', Seminars in arthritis and rheumatism, vol. 65, 152388. https://doi.org/10.1016/j.semarthrit.2024.152388 | en |
| dc.identifier.doi | 10.1016/j.semarthrit.2024.152388 | |
| dc.identifier.issn | 0049-0172 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/159078448 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23395 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85184021202&partnerID=8YFLogxK | en |
| dc.identifier.vol | 65 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Seminars in arthritis and rheumatism | en |
| dc.subject | Biologic therapy | en |
| dc.subject | Clinical study in epidemiology | en |
| dc.subject | Cohort study | en |
| dc.subject | Rheumatic diseases | en |
| dc.subject | Spondyloarthritis | en |
| dc.subject | RS Pharmacy and materia medica | en |
| dc.subject | Rheumatology | en |
| dc.subject | Anesthesiology and Pain Medicine | en |
| dc.subject.lcc | RS | en |
| dc.title | Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Christiansen_etal_SAR_Patient-reported_Outcomes_in_VOR.pdf
- Size:
- 2.3 MB
- Format:
- Adobe Portable Document Format
